01:10 PM EDT, 04/01/2026 (MT Newswires) -- Health care stocks rose Wednesday afternoon, with the NYSE Health Care Index and the State Street Health Care Select Sector SPDR ETF (XLV) each adding 1.2%.

The iShares Biotechnology ETF (IBB) rose 1.4%.

In corporate news, Eli Lilly ( LLY ) said Wednesday the US Food and Drug Administration approved its once-daily oral glucagon-like peptide-1 receptor agonist, Foundayo, for adults with obesity or overweight with weight-related medical conditions. Lilly shares jumped 5.1%.